期刊文献+

2-(E)-(4-环戊氧基-3-甲氧基苯亚甲基)环戊酮芳胺Mannich碱类化合物的合成及抗肿瘤活性 被引量:10

Synthesis and antitumor activities of 2-(E)-(4-cyclopentyloxy-3-methylbenzylidene) cyclopentanone arylamine Mannich bases
下载PDF
导出
摘要 目的设计合成一系列2-(E)-(4-环戊氧基-3-甲氧基苯亚甲基)环戊酮Mannich碱类化合物,并对其抗肿瘤活性进行体外试验。方法以环戊酮为原料,经Stock反应、Williamson反应、Mannich反应和芳胺交换反应合成目标化合物。结果合成12个未见文献报道的新化合物,化合物的结构经1H-NMR、IR和元素分析确证。用人肝癌细胞(Bel-7402)、人口腔癌细胞(KB)进行体外抗肿瘤活性试验。初步体外活性筛选结果显示,化合物Ⅰ9具有较高的活性,对Bel-7402和KB细胞的IC50值分别为0.98、2.19μmol.L-1,但低于阳性对照药氟脲嘧啶。结论在苯亚甲基环戊酮2位侧链氨基连接的苯环的2、3、4位引入供电子基,或者在对位引入,可提高化合物活性,但在对位引入诱导效应的卤素原子,其活性下降。 Aim To design and synthesize a series of 2-( E )-(4-cyclopentyloxy-3-methylbenzylidene) cyclopentanone arylamine Mannich bases, and to determine their antitumor activities in vitro. Methods The target compounds were synthesized by Stock enamine reaction, Williamson reaction, Mannich reaction, and arylamine exchange reaction with cyclopentanone as starting material, and their antitumor activities were assayed using human hepatic carcinoma cell line (Bel-7402), human oral cavity epidermis squamocellular carcinoma cell line (KB). Results Twelve compounds were obtained and they were not reported in the literature, and their chemical structures were identified by ^1H-NMR, IR and elemental analysis. Preliminary antitumor screening bioassay in vitro showed that target compound Ⅰ 9 possessed better biological activity with IC40 value 0.98 μmol·L^-1 and 2.19 μmol·L^-1 for Bel-7402 and KB carcinoma cell respectively, while lower than flurouracil (5-Fu) as postive control. Conclusion This results indicate that introduction of electron-attractive substitutes at position 2, 3 and 4, or electron-withdrawn substitutes at 4 position of amino-linked benzene ring on basic side chain of methylbenzylidenecyclopentanone contributed to the increase of anticancer activity, while introduction of halogen atoms such as chlorine and bromine with induction effect at 4 position of amino-linked benzene ring on basic side chain contributed to the decrease of the anticancer activity of target compounds.
出处 《中国药物化学杂志》 CAS CSCD 2006年第3期144-149,共6页 Chinese Journal of Medicinal Chemistry
基金 广东省自然科学基金博士启动项目(994615)
关键词 药物化学 Ca合物制备 化学合成 取代苯亚甲基环戊酮Mannich碱 抗肿瘤活性 medicinal chemistry compound preparation chemical synthesis substituted benzylidenecyclopentanone Mannich bases antitumor activity
  • 相关文献

参考文献10

  • 1Chen HT, Ji ZZ, Wong LK, et al. Synthesis and anticancer activity of 2-alkylaminomethyl-5-( E )-alkylidene cyclopentanone hydrochloride [ J ]. Bioorg Med Chem, 1994, 2( 10):1091 - 1097. 被引量:1
  • 2陈海涛,计志忠.含有α-亚甲基-γ-丁内酯的天然产物及其结构类似物的抗癌、抗炎活性[J].中国药物化学杂志,1994,4(2):137-149. 被引量:13
  • 3El-Subbagh HI, Abu-Zaid SM, Mahran MA, et al.Synthesis and biological evaluation of certain a, β-unsaturated ketones and their corresponding fused pyridines as antiviral and cytotoxic agents[J]. J Med Chem, 2000, 43 (15) : 2915 - 2921. 被引量:1
  • 4Dinkova-Kostova AT, Massiah MA, Bozak RE, et al.Potency of Michael reaction acceptors as inducers of enzymes that protect against carcinogenesis depends on their reactivity with sulfhydryl groups [J ]. Proc Natl Acad Sci USA, 2001, 98(6) : 3404 - 3409. 被引量:1
  • 5Dimmock JR, Kumar P. Anticancer and cytotoxic properties of Mannich bases [J ]. Curr Med Chem,1997,4(1) : 1-22. 被引量:1
  • 6Chang JY, Hsieh HP, Pan WY, et al. Dual inhibition of topoisomerase I and tubulin polymerization by BPROY007, a novel cytotoxic agent [ J ]. Biochem Pharmacol, 2003, 65 (12) : 2009 - 2019. 被引量:1
  • 7Juang SH, Pan WY, Kuo CC, et al. A novel bis-benzylidenecyclopentanone derivative, BPROY007, inducing a rapid caspase activation involving upregulation of Fas(CD95/APO-1) and wild-type p53 in human oral epidermoid carcinoma cells[J] .Biochem Pharmacol, 2004, 68(2) : 293 - 303 被引量:1
  • 8Chen HT, Ji ZZ, Wong LK, et al. Synthesis, antiin-flammatory, and cytotoxic activities of 2-alkyl and 2-benzyl-2-dimethylaminomethyl-5-( E )-arylidene cyclopentanone hydrochloride[J ]. Pharm Res, 1996, 13(10) : 1482 - 1487. 被引量:1
  • 9李述文 范如霖.实用有机化学手册[M].上海:上海科学技术出版社,1986.345. 被引量:10
  • 10Ashton MJ, Cook DC, Fenton G, et al. Selective type Ⅳ phosphodiesterase inhibitors as anti-asthmate agents. The synthesis and biological activities of 3-(cyclopentyloxy)-4-methyloxybenzamides and analogues[J] .J Med Chem, 1994,37(11):1696- 1703. 被引量:1

共引文献21

同被引文献65

引证文献10

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部